Pathology Watch Acquired by Sonic Healthcare for $150 Million

by | Nov 16, 2023

Salt Lake City-based Pathology Watch has announced it has been acquired by Sonic Healthcare, headquartered in Sydney, Australia, for $150 million. Sonic will fund the acquisition from existing cash reserves and debt. The deal is expected to close in December 2023.

Sonic has called the acquisition a strategic move that will accelerate its transition to digital pathology services. While Pathology Watch is at the pre-profit stage, Sonic expects to grow its earnings-per-share and return-on-invested-capital in coming years.

Pathology Watch’s founders, management and staff will join the ASX-listed company’s U.S. and global operations.

Read the full article here.


Published November 16, 2023
SpringTide is a network of entrepreneurs who’ve pooled capital, access to great companies, and expertise to solve big problems in medicine.

Join the Community

We are entrepreneurs, investors, builders, operators, and thinkers. We are optimists. We are our founders’ biggest fans.